We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
New funding to local authorities to help them improve their drug and alcohol treatment and recovery systems, from 2023 to 2025.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
How clinicians should treat people with drug misuse and drug dependence problems.
Evidence and guidance to help health professionals identify, prevent or reduce drug-related harm.
A qualitative study
Advice on best practice for reviewing individuals in substance misuse treatment.
This study relates to Syrian refugees and the host population with hypertension and diabetes in Jordan.
Guidance for healthcare and public health commissioners on planning treatment services for dependence on prescription and over-the-counter medicines.
Torrent Pharma (UK) Limited is recalling certain batches of Ramipril 1.25mg tablets as a precautionary measure due to these batches having a low assay and high related substances test results after their release to the market.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).